Aqualung Therapeutics Corporation Receives A $2.3 Million National Institute Of Health (NIH) Fast-Track Award To Develop A Novel Therapeutic Antibody For Patients With Radiation-Induced Lung Injury
TUCSON, AZ / ACCESSWIRE / June 2, 2020 / Aqualung Therapeutics, an early-stage biotech company…
ModelOp Recognized in 2025 Gartner® Market Guide for AI Governance Platforms
Market Value Lower Than Cash Assets? It’s Time to Reevaluate NIVF
Winvest Group Announces Strategic Partnership with Greater Bay Area RWA Incubator; Southeast Asia Headquarters to Be Established in Malaysia